ArticleBMC cardiovascular disorders2026
Modifiable risk factors in type 1 cardiorenal syndrome in children with congenital heart disease: a retrospective cohort study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute kidney injury (AKI) is a frequent complication in neonates undergoing surgical correction of congenital heart defects (CHD), associated with increased morbidity and mortality. However, evidence from Central Asian pediatric populations remains scarce, particularly regarding timing, severity, and perioperative risk factors.
methodsA retrospective cohort study was conducted at the Pediatric Cardiac Intensive Care Unit of UMC “Heart Center,” Astana, Kazakhstan (January 2023–July 2024). Postoperative AKI was defined and staged according to Kidney Disease: Improving Global Outcomes (KDIGO) neonatal criteria, using both serum creatinine and hourly urine output within the first 7 postoperative days and throughout the ICU stay. Clinical, laboratory, and perioperative factors, including gestational age, birth weight, intraoperative bleeding, blood pressure, and cardiopulmonary bypass (CPB) duration, were analyzed. Renal replacement therapy (peritoneal dialysis or continuous renal replacement therapy) was initiated based on oliguria, rising creatinine, or electrolyte imbalance.
resultsAmong 124 neonates, 74 (59.7%) developed AKI, most within the first postoperative week. The maximum AKI stages were: stage 1–30/74 (40.5%), stage 2–24/74 (32.4%), and stage 3–20/74 (27.0%). Renal replacement therapy was required in 22/124 (17.7%) patients (peritoneal dialysis in 18, CRRT in 4). AKI was associated with lower gestational age, lower birth weight, prolonged CPB, and intraoperative hypotension. In multivariable analysis, sepsis (HR 3.5, p = 0.01), male sex (HR 1.8, p = 0.04), and hyponatremia (< 130 mmol/L; OR 4.1, p < 0.001) independently predicted AKI. The “age” variable reflected minor postnatal age differences within the neonatal period. AKI was associated with longer ICU stay and higher mortality (33.3% vs. 0%, p < 0.001).
conclusionPostoperative AKI is common in neonates undergoing corrective CHD surgery and is strongly associated with perioperative instability and sepsis. Early recognition and timely renal support, including peritoneal dialysis as a supportive measure, may improve short-term management. These findings provide region-specific data from a Central Asian tertiary center and underscore the importance of systematic renal monitoring in resource-limited pediatric settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.